WARPNINE is a not-for-profit clinical research organisation based in Western Australia. It is focused on improving outcomes for patients with pancreatic, gastrointestinal, and rare cancers.
Led by CEO Meg Croucher, WARPNINE conducts patient-centred clinical trials to accelerate breakthrough treatments for these aggressive cancers.
Learn more at www.warpnine.org.au.
Contact: [email protected] | 0406 818 810
